Additionally, Tregs can reshape the profiles of immune cells within the tumor, suppressing IFN-γ secretion by CD8+ T cells and promoting the development of OS-M through sterol regulatory element-binding protein 1 (SREBP1)-mediated fatty acid synthesis [175,176]. The gene discussed is SREBF1; the disease is neoplasm.